COVID-19 vaccination and type 2 diabetes mellitus

According to data on mortality and morbidity collected during the coronavirus pandemic, complications caused by the new coronavirus infection were especially dangerous for elderly people and patients with chronic diseases, including type 2 diabetes mellitus.

Diabetic patients are at high risk of infection and severe course of COVID-19. The risks of hospitalization, the development of acute respiratory distress syndrome, thrombotic complications, and fatal outcome are higher for them. In addition, most patients with type 2 diabetes are obese, which further increases the risk of death.

Vaccination is a key tool for reducing morbidity and mortality rates. Given the possibility of preventing a severe course of COVID-19 and reducing hospitalizations, vaccination of high-risk adult patients is a crucial task. Health care systems of different countries recommend vaccination of diabetic patients as a first priority. 

Find out more about vaccinations on the website of the Ministry of Health of the Russian Federation and the Ministry of Social Affairs of Estonia.